Market revenue in 2023 | USD 37.8 million |
Market revenue in 2030 | USD 93.1 million |
Growth rate | 13.7% (CAGR from 2023 to 2030) |
Largest segment | Spinal cord stimulator |
Fastest growing segment | Sacral Nerve Stimulator |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator |
Key market players worldwide | Medtronic PLC, LivaNova PLC, Boston Scientific Corp, St. Jude Medical, Nevro Corp |
Spinal cord stimulator was the largest segment with a revenue share of 47.09% in 2023. Horizon Databook has segmented the UAE neurostimulation devices market based on spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, gastric electric stimulator covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE is facing a shortage of medical trade personnel. For instance, according to the Dubai Health Authority (DHA), there is likely to be a need for about 8,000 additional beds in Dubai by 2025. As per the country’s current provisions, medical facilities are free of cost for UAE citizens.
These factors may restrain market growth. However, due to the medical facilities provided to the citizens & healthcare professionals, the demand for neurostimulation devices in the UAE is expected to increase in the coming years.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account